Algert Global’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,103
| Closed | -$221K | – | 1150 |
|
|
2021
Q3 | $221K | Sell |
1,103
-58
| -5% | -$11.6K | 0.03% | 873 |
|
|
2021
Q2 | $297K | Sell |
1,161
-147
| -11% | -$37.6K | 0.1% | 289 |
|
|
2021
Q1 | $347K | Sell |
1,308
-1,929
| -60% | -$512K | 0.11% | 278 |
|
|
2020
Q4 | $1.19M | Sell |
3,237
-16
| -0.5% | -$5.9K | 0.34% | 109 |
|
|
2020
Q3 | $794K | Buy |
3,253
+2
| +0.1% | +$488 | 0.25% | 145 |
|
|
2020
Q2 | $936K | Sell |
3,251
-224
| -6% | -$64.5K | 0.32% | 115 |
|
|
2020
Q1 | $709K | Buy |
3,475
+1,712
| +97% | +$349K | 0.3% | 126 |
|
|
2019
Q4 | $788K | Buy |
1,763
+199
| +13% | +$88.9K | 0.24% | 148 |
|
|
2019
Q3 | $481K | Buy |
1,564
+605
| +63% | +$186K | 0.18% | 158 |
|
|
2019
Q2 | $305K | Buy |
959
+371
| +63% | +$118K | 0.11% | 223 |
|
|
2019
Q1 | $247K | Sell |
588
-1,347
| -70% | -$566K | 0.14% | 221 |
|
|
2018
Q4 | $590K | Sell |
1,935
-329
| -15% | -$100K | 0.16% | 199 |
|
|
2018
Q3 | $815K | Buy |
2,264
+1,507
| +199% | +$542K | 0.18% | 195 |
|
|
2018
Q2 | $277K | Buy |
+757
| New | +$277K | 0.06% | 293 |
|